Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-11-15 Sale | 2024-11-18 4:03 pm | ANI PHARMACEUTICALS INC | ANIP | Mutz Christopher HEAD OF RARE DISEASE | 6,500 | $57.7 | $375,050 | 76,777 (Direct) | View |
2024-05-21 Sale | 2024-05-22 6:14 pm | ANI PHARMACEUTICALS INC | ANIP | Mutz Christopher HEAD OF RARE DISEASE | 2,000 | $61.61 | $123,220 | 83,277 (Direct) | View |
2024-03-05 Sale | 2024-03-06 4:24 pm | ANI PHARMACEUTICALS INC | ANIP | Mutz Christopher HEAD OF RARE DISEASE | 5,000 | $66 | $330,000 | 87,387 (Direct) | View |
2023-11-10 Sale | 2023-11-13 4:02 pm | ANI PHARMACEUTICALS INC | ANIP | Mutz Christopher HEAD OF RARE DISEASE | 3,000 | $52.47 | $157,410 | 63,607 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-03-07 Tax Withholding | 2024-03-07 9:16 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Mutz Christopher HEAD OF RARE DISEASE | 2,110 | $66.71 | 85,277 (Direct) | View |
2024-02-29 Tax Withholding | 2024-03-01 5:12 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Mutz Christopher HEAD OF RARE DISEASE | 1,275 | $67.67 | 92,387 (Direct) | View |
2024-02-15 Tax Withholding | 2024-02-20 5:02 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Mutz Christopher HEAD OF RARE DISEASE | 1,261 | $57.55 | 93,662 (Direct) | View |
2024-02-14 Option Award | 2024-02-16 4:50 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Mutz Christopher HEAD OF RARE DISEASE | 31,316 | $0 | 94,923 (Direct) | View |
2023-02-28 Option Award | 2023-04-04 8:07 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Mutz Christopher HEAD OF RARE DISEASE | 28,947 | $0 | 66,607 (Direct) | View |
2023-03-07 Tax Withholding | 2023-03-09 6:48 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Mutz Christopher HEAD OF RARE DISEASE | 1,902 | $44.23 | 37,660 (Direct) | View |
2023-02-15 Tax Withholding | 2023-02-17 4:32 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Mutz Christopher HEAD OF RARE DISEASE | 1,292 | $45.04 | 39,562 (Direct) | View |
2022-04-27 Option Award | 2022-04-29 6:37 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Mutz Christopher HEAD OF RARE DISEASE | 6,476 | $0 | 40,854 (Direct) | View |
2022-03-24 Option Award | 2022-03-28 8:51 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Mutz Christopher HEAD OF RARE DISEASE | 19,428 | $0 | 34,378 (Direct) | View |
2022-02-15 Tax Withholding | 2022-02-17 7:24 pm | N/A N/A | ANI PHARMACEUTICALS INC | ANIP | Mutz Christopher HEAD OF RARE DISEASE | 1,184 | $40.25 | 14,950 (Direct) | View |
2021-02-15 Option Award | 2021-02-17 9:57 pm | N/A 2031-02-15 | ANI PHARMACEUTICALS INC | ANIP | Mutz Christopher CHIEF COMMERCIAL OFFICER | 49,892 | $0 | 49,892 (Direct) | View |